Many prescription drugs have patent protections that deliver monopoly pricing power to their...
What’s Buzzing
To reduce risk of bankruptcy, plan ahead for retirement
A new survey by the Consumer Bankruptcy project reveals that a growing number of older adults find...
2019 Social Security benefits should rise, but checks may not
As a result of inflation, people on fixed incomes find that their incomes decline in value over...
Medicare for All is the only realistic way to rein in health...
My recent op-ed in the Washington Post explains why we cannot afford to live without Medicare for...
Guaranteeing coverage to people with pre-existing conditions...
According to a new Kaiser survey, a majority of voters say that a federal candidate’s...
Public believes Trump’s drug plan will not lower drug...
The public wants the federal government to address prescription drug prices. President Trump has...
Doing away with drug rebates alone will not bring down drug costs
Pharmaceutical companies charge too much for their drugs. And, they probably charge more because...
AstraZeneca CEO calls excessive price hikes modest
StatNews reports that AstraZeneca CEO, Pascal Soriot, already has hiked prescription drug prices...
Congressman Doggett takes lead on Medicare drug price...
Congressman Lloyd Doggett of Texas, along with 59 other House Democrats, just introduced a bill...
Anthem keeps people from getting ER care simply by claiming it...
The New York Times has a follow-up story on Anthem, the insurer that unconscionably denied some of...